Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Professional guidance helps navigate these individual differences while maximizing therapeutic benefits.
No human clinical trials of 5-Amino-1MQ in obesity, sarcopenia, or any other indication have been published in peer-reviewed journals
It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
FAQs about AOD-9604 Usage
NAD+ alone benefits many, but adding 5-Amino-1MQ amplifies effects for: Adults 40+ with aging signs (fatigue, fog, skin issues): Restores vitality and reduces wrinkles
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 23.88
US$ 28.15
US$ 22.40
